[{"address1": "21925 W. Field Parkway", "address2": "Suite 235", "city": "Deer Park", "state": "IL", "zip": "60010-7208", "country": "United States", "phone": "847 787 7361", "website": "https://www.etonpharma.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and dehydrated alcohol injection to treat methanol poisoning. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis; Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis; EPRONTIA, a liquid formulation of topiramate; ZONISADE, a liquid formulation of zonisamide for the treatment of partial seizures in patients with epilepsy; and Lamotrigine for Oral Suspension for the treatment of epilepsy. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.", "fullTimeEmployees": 30, "companyOfficers": [{"maxAge": 1, "name": "Mr. Sean E. Brynjelsen", "age": 51, "title": "President, CEO & Director", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": 868126, "exercisedValue": 0, "unexercisedValue": 290000}, {"maxAge": 1, "name": "Mr. James R. Gruber CPA", "age": 51, "title": "CFO, Treasurer & Secretary", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": 457584, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David C. Krempa", "age": 34, "title": "Chief Business Officer", "yearBorn": 1989, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ingrid  Hoos", "title": "Senior Vice President of Regulatory Affairs", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kevin  Guthrie", "title": "Executive VP of Commercial Operations", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 4.46, "open": 4.0, "dayLow": 3.85, "dayHigh": 4.21, "regularMarketPreviousClose": 4.46, "regularMarketOpen": 4.0, "regularMarketDayLow": 3.85, "regularMarketDayHigh": 4.21, "beta": 1.186, "forwardPE": 14.807693, "volume": 196142, "regularMarketVolume": 196142, "averageVolume": 71029, "averageVolume10days": 73080, "averageDailyVolume10Day": 73080, "bid": 4.56, "ask": 4.6, "bidSize": 800, "askSize": 1200, "marketCap": 98899184, "fiftyTwoWeekLow": 2.42, "fiftyTwoWeekHigh": 5.81, "priceToSalesTrailing12Months": 3.1255667, "fiftyDayAverage": 4.4762, "twoHundredDayAverage": 4.0613, "currency": "USD", "enterpriseValue": 82966040, "profitMargins": -0.029579999, "floatShares": 19897459, "sharesOutstanding": 25688100, "sharesShort": 227190, "sharesShortPriorMonth": 383967, "sharesShortPreviousMonthDate": 1706659200, "dateShortInterest": 1709164800, "sharesPercentSharesOut": 0.0089, "heldPercentInsiders": 0.12968999, "heldPercentInstitutions": 0.27892, "shortRatio": 4.72, "shortPercentOfFloat": 0.0093, "impliedSharesOutstanding": 25688100, "bookValue": 0.602, "priceToBook": 6.3953485, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -936000, "trailingEps": -0.04, "forwardEps": 0.26, "enterpriseToRevenue": 2.622, "enterpriseToEbitda": -231.749, "52WeekChange": -0.022842646, "SandP52WeekChange": 0.29495108, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "ETON", "underlyingSymbol": "ETON", "shortName": "Eton Pharmaceuticals, Inc.", "longName": "Eton Pharmaceuticals, Inc.", "firstTradeDateEpochUtc": 1542119400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "fbcd977f-686a-3d1e-ae47-b3ae800e35f4", "messageBoardId": "finmb_435353222", "gmtOffSetMilliseconds": -14400000, "currentPrice": 3.85, "recommendationMean": 2.0, "recommendationKey": "buy", "totalCash": 21388000, "totalCashPerShare": 0.833, "ebitda": -358000, "totalDebt": 5455000, "quickRatio": 1.527, "currentRatio": 1.653, "totalRevenue": 31642000, "debtToEquity": 35.246, "revenuePerShare": 1.234, "returnOnAssets": -0.02625, "returnOnEquity": -0.065560006, "freeCashflow": 5600500, "operatingCashflow": 6815000, "revenueGrowth": -0.139, "grossMargins": 0.6656, "ebitdaMargins": -0.01131, "operatingMargins": -0.27253, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-03-17"}]